Skip to content
Research Article Open access CC BY 4.0

The Prevalence of Symptomatic Vulvo-vaginal Candidiasis and Trichomonas vaginalis Infection and Associated Risk Factors among Women in the Niger Delta Region of Nigeria

Kemebradikumo Pondei, Israel Jeremiah, Ebidor Lawani, Etim Nsikak

International STD Research & Reviews · pp. 1–10 · Published 24 Mar 2017

10.9734/ISRR/2017/32057

Abstract

Aims: This study aims to determine the prevalence of symptomatic vulvo-vaginal candidiasis and trichomoniasis and risk factors among women presenting at the outpatient departments of two tertiary health institutions in the Niger Delta region of Nigeria. Study Design:  A prospective cross-sectional study. Place and Duration of Study: The study was carried out at the Niger Delta University Teaching Hospital (NDUTH), Okolobiri and the Federal Medical Centre (FMC), Yenagoa, both in Bayelsa State, Nigeria between February 2012 and May 2013. Methodology: 1240 patients presenting with vaginal symptoms: discharge, itching, soreness or burning sensation were consecutively recruited for the study. High vaginal and endocervical swabs were taken from the women and examined microscopically for motile trichomonads and yeasts, and cultured on appropriate media. Gram staining and Germ tube test were used to identify the organisms. A structured questionnaire was used to obtain patient information relevant to the study. IBM SPSS 21 for Windows® was used for statistical analysis. Variables were compared using the Student’s t-test and Fisher’s Exact test. P values less than 0.05 were considered significant. Results: The prevalence of VVC was 25.7% (319 subjects), and only Candida albicans genus was isolated from the samples. Bacterial culture was positive in 34.3% of the subjects and Trichomonas vaginalis identified in 6.5% of the samples. Prevalence of co-infection with C. albicans and T. vaginalis was 2.6%.  Most of the subjects with VVC and T. vaginalis infection were in the 21 years to 30 years age group. Diabetes mellitus (p<0.01), being a student (p<0.01) and being single (p<0.01) were significantly associated with C. albicans infection and T. vaginalis infection. Pregnancy was significantly associated with C. albicans infection (p=0.04).  The use of low-oestrogen oral contraceptives had no significant association with C. albicans or T. vaginalis infection. Conclusion: Symptomatic VVC and T. vaginalis infection were found to be common in the Niger Delta region of Nigeria. Risk factors include diabetes mellitus, pregnancy, being single and being a student. Clearly defined clinical guidelines for symptomatic vulvovaginitis management are needed.

Vulvo-vaginal candidiasis trichomoniasis risk factors prevalence symptoms

References (39)

  1. 1 Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women [DOI]
  2. 2 Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery [DOI]
  3. 3 Candida Infections of the Genitourinary Tract [DOI]
  4. 4 The Prevalence of Trichomonas vaginalis Infection among Reproductive-Age Women in the United States, 2001-2004 [DOI]
  5. 5 Infection with Trichomonas vaginalis Increases the Risk of HIV‐1 Acquisition [DOI]
  6. 6 Recurring urinary tract infection: incidence and risk factors. [DOI]
  7. 7 Genital tract infections and infertility [DOI]
  8. 8 Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis [DOI]
  9. 9 Trichomonas vaginalis Is Associated with Pelvic Inflammatory Disease in Women Infected with Human Immunodeficiency Virus [DOI]
  10. 10 Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm [DOI]
  11. 11 Rapid Antigen Testing Compares Favorably with Transcription-Mediated Amplification Assay for the Detection of Trichomonas vaginalis in Young Women [DOI]
  12. 12 Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy [DOI]
  13. 13 Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification Assay [DOI]
  14. 14 Prevalence, Incidence, Natural History, and Response to Treatment ofTrichomonas vaginalisInfection among Adolescent Women [DOI]
  15. 15 Trichomonas vaginalis Vaginitis in Obstetrics and Gynecology Practice [DOI]
  16. 16 Trichomonas vaginalis Prevalence, Incidence, Risk Factors and Antibiotic-Resistance in an Adolescent Population [DOI]
  17. 17 Risk Factors for Vulvovaginal Candidiasis [DOI]
  18. 18 Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status [DOI]
  19. 19 The Associations Between Pelvic Inflammatory Disease, Trichomonas vaginalis Infection, and Positive Herpes Simplex Virus Type 2 Serology [DOI]
  20. 20 Trichomonas vaginalis and cervical cancer [DOI]
  21. 21 Oestrogen, glycogen and vaginal candidiasis [DOI]
  22. 22 Frequency and Response to Vaginal Symptoms among White and African American Women: Results of a Random Digit Dialing Survey [DOI]
  23. 23 Candida Albicans: The Estrogen Target for Vaginal Colonization [DOI]
  24. 24 Etiology and STI/HIV Coinfections Among Patients With Urethral and Vaginal Discharge Syndromes in South Africa [DOI]
  25. 25 Candida Transmission and Sexual Behaviors as Risks for a Repeat Episode of Candida Vulvovaginitis [DOI]
  26. 26 A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis [DOI]
  27. 27 Chronic vulvovaginal candidiasis.
  28. 28 Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods [DOI]
  29. 29 The pill does not cause ‘thrush’ [DOI]
  30. 30 The association of Candida infection with intrauterine contraceptive device.
  31. 31 Symptomatic vulvovaginal candidiasis and genital colonization by Candida species in Nigeria [DOI]
  32. 32 Prevalence of trichomonas vaginalis infections among antenatal clients in Maiduguri Nigeria
  33. 33 The incidence of candidiasis amongst the asymptomatic female students of the University of Jos, Nigeria [DOI]
  34. 34 Effect of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State, Nigeria [DOI]
  35. 35 Trichomonas Vaginalis Infection Among Pregnant Women In Calabar, Cross River State, Nigeria. [DOI]
  36. 36 Prevalence of HIV among women with vaginal discharge in a gynecological clinic.
  37. 37 Trichomonas Vaginalis infection among women in Ikwuano Abia State Nigeria. [DOI]
  38. 38 The prevalence of Trichomonas vaginalis and Candida albicans infection in the lower genital tracts of antenatal patients in Abakaliki, Southeastern Nigeria [DOI]
  39. 39 Trichomonas vaginalis infection in human immunodeficiency virus-seropositive Nigerian women: The public health significance

Cited by 10

Vulvovaginal candidiasis: A global perspective through systematic review and meta-analysis

Zahra Rafat, Nadia Alipour, Ehsan Esmaeili · Microbial Pathogenesis · 2026

Occurrence and Clinical Characteristics of Vaginitis among Women of Reproductive Age in Lagos, Nigeria

Chinedum Taahie Oparaugo, Bamidele Abiodun Iwalokun, Francisca Obiageri Nwaokorie · Advances in Reproductive Sciences · 2022

Investigating the Frequency of Candida glabrata in Diabetic Women of Tehran with Recurrent and Non-recurrent Vulvovaginal Candidiasis Using PCR-RFLP Assay

Mansoureh Paknejadi, Department of Pathobiology, Science and Research Branch, Islamic Azad University, Tehran, Iran, Mansour Bayat · Journal of Medical Microbiology and Infectious Diseases · 2019

Showing 4 of 10 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

54

Page views

0

PDF downloads

10

Outbound clicks

10

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.